Clearwater analytics chief revenue officer sells $3.72 million in stock

BOISE, ID—Scott Stanley Erickson, the Chief Revenue Officer of Clearwater Analytics Holdings , Inc. (NYSE:CWAN), a $7.62 billion market cap company whose stock has surged 71% over the past year, has recently executed a series of stock transactions, according to a filing with the Securities and Exchange Commission.

On March 3, Erickson sold a total of 120,863 shares of Clearwater Analytics Class A common stock, valued at approximately $3.72 million. The sales were conducted at prices ranging from $30.18 to $30.8029 per share, near the stock’s current trading level of $30.07. These transactions were part of a pre-established Rule 10b5-1 trading plan that Erickson adopted on November 22, 2024. According to InvestingPro data, the company maintains strong liquidity with a current ratio of 4.99x and operates with moderate debt levels.

In addition to the sales, Erickson also exercised stock options to acquire 9,722 shares at a price of $4.00 per share. Following these transactions, Erickson now holds 7,902 shares of the company’s stock directly.

The transactions were filed under the SEC’s Form 4, which is required for any changes in the holdings of company insiders.

In other recent news, Clearwater Analytics Holdings reported strong fourth-quarter 2024 earnings, surpassing Wall Street expectations with an earnings per share of $0.13, compared to the forecasted $0.11. The company’s revenue reached $126.5 million, exceeding the anticipated $120.39 million, marking a 28% year-over-year increase. Clearwater’s Annual Recurring Revenue (ARR) grew by 25.3% to $474.9 million, supported by a Net Revenue Retention (NRR) rate of 116%, achieving the company’s fiscal year 2025 exit goal a year early. Piper Sandler upgraded Clearwater’s stock rating from Neutral to Overweight and raised the price target from $28.00 to $36.00, citing the company’s robust earnings performance and the strategic acquisition of Enfusion. DA Davidson also maintained a Buy rating with a $32.00 price target following Clearwater’s strong quarterly results and optimistic future guidance. The acquisition of Enfusion is seen as a strategic move to enhance Clearwater’s platform capabilities, particularly in regulatory reporting and compliance. Analysts from Piper Sandler believe that the merger will improve Clearwater’s competitive edge and create opportunities for cross-selling and upselling. For 2025, Clearwater projects revenue between $535.5 million and $542 million, indicating a growth rate of 19-20%.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.